HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transmission of familial Mediterranean fever mutation after bone marrow transplantation and successful treatment with anakinra.

AuthorsAnna D Petropoulou, Marie Robin, Gérard Socié, Lionel Galicier
JournalTransplantation (Transplantation) Vol. 90 Issue 1 Pg. 102-3 (Jul 15 2010) ISSN: 1534-6080 [Electronic] United States
PMID20606570 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Bacterial Agents
  • Antilymphocyte Serum
  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Cyclosporine
Topics
  • Anemia, Aplastic (surgery)
  • Anti-Bacterial Agents (therapeutic use)
  • Antilymphocyte Serum (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Bone Marrow Transplantation (adverse effects)
  • Cyclosporine (therapeutic use)
  • Familial Mediterranean Fever (drug therapy, genetics)
  • Graft vs Host Disease (prevention & control)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Informed Consent
  • Interleukin 1 Receptor Antagonist Protein (therapeutic use)
  • Male
  • Mutation
  • Stroke Volume
  • Transplantation, Homologous (adverse effects)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: